Serum metabolic profile in early multiple sclerosis as predictor of long-term disease progression in BENEFIT (P5-3.013)
Marianna Cortese(Harvard University), Alberto Ascherio(Harvard University), Eva‐Maria Wicklein(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ludwig Kappos(University Hospital of Basel), Ernst‐Wilhelm Radue, Clary B. Clish(Broad Institute), Hans‐Peter Hartung(The University of Sydney), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Rupert Sandbrink(Io Therapeutics (United States)), Kjetil Bjørnevik(Harvard University), Kassandra L. Munger(Biogen (United States)), Xiaojing Peng(Harvard University), Mark Freedman(Ottawa Hospital), Gilles Edan(Inserm), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya)
Cited by 0
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k